This evidence reveals that the status of FAS and PVR genes may represent a novel biomarker predicting the outcome of NB patients, thus suggesting that their restoration could improve disease status through an immunomodulatory action that could involve NK-cell-mediated innate anti-tumor functions. The gene discussed is PVR; the disease is neuroblastoma.